|

Oral arsenic trioxide Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2: 1

Top Sponsors

  • The University of Hong Kong1

Indications

  • Arsenic Trioxide1
  • TP53 Gene Mutation1
  • Myelodysplastic Neoplasm1
  • Chronic Myelomonocytic Leukemia1
  • Acute Myeloid Leukemia1

Other1 trial

Oral-ATO for TP53-mutated Myeloid Malignancies
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.